comparemela.com

Latest Breaking News On - Institutional investors weigh in on tonix pharmaceuticals - Page 3 : comparemela.com

Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Rating Upgraded by StockNews.com

StockNews.com upgraded shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) to a sell rating in a report published on Tuesday. Separately, Alliance Global Partners decreased their price target on Tonix Pharmaceuticals from $18.00 to $8.00 and set a buy rating for the company in a research note on Tuesday. Tonix Pharmaceuticals Trading Down 2.5 % […]

Millennium-management
Alliance-global-partners
Jpmorgan-chase-co
Tonix-pharmaceuticals-holding-corp
Tonix-pharmaceuticals
Geode-capital-management
Institutional-investors-weigh-in-on-tonix-pharmaceuticals
News-ratings-for-tonix-pharmaceuticals-daily
Charles-schwab-investment-management-inc
Tonix-pharmaceuticals-trading-down
Free-report

Tonix Pharmaceuticals (NASDAQ:TNXP) PT Lowered to $8.00 at Alliance Global Partners

Tonix Pharmaceuticals (NASDAQ:TNXP) PT Lowered to $8.00 at Alliance Global Partners
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Millennium-management
Tonix-pharmaceuticals-company-profile
Alliance-global-partners
Tonix-pharmaceuticals
Virtu-financial
Tonix-pharmaceuticals-trading-down
Institutional-investors-weigh-in-on-tonix-pharmaceuticals
News-ratings-for-tonix-pharmaceuticals-daily
Tonix-pharmaceuticals-holding-corp
Nasdaq
Raymond-james-associates

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Sees Significant Growth in Short Interest

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) was the recipient of a large increase in short interest in June. As of June 30th, there was short interest totalling 1,500,000 shares, an increase of 32.7% from the June 15th total of 1,130,000 shares. Approximately 14.5% of the company’s stock are short sold. Based on […]

Tonix-pharmaceuticals-stock
Tonix-pharmaceuticals
Blackrock-inc
York-mellon-corp
Tonix-pharmaceuticals-holding-corp
Charles-schwab-investment-management-inc
News-ratings-for-tonix-pharmaceuticals-daily
Nasdaq
Institutional-investors-weigh-in-on-tonix-pharmaceuticals
Northern-trust-corp
Jpmorgan-chase-co

Tonix Pharmaceuticals (NASDAQ:TNXP) Coverage Initiated at StockNews.com

Stock analysts at StockNews.com began coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Get Rating) in a research report issued on Thursday. The brokerage set a “sell” rating on the stock. Tonix Pharmaceuticals Stock Performance Shares of NASDAQ TNXP traded down $0.03 during mid-day trading on Thursday, reaching $1.86. The company’s stock had a trading […]

Jpmorgan-chase-co
Tonix-pharmaceuticals-stock-performance
Tonix-pharmaceuticals-holding-corp
Tonix-pharmaceuticals
Virtu-financial
News-ratings-for-tonix-pharmaceuticals-daily
Tonix-pharmaceuticals-company-profile
Raymond-james-associates
Institutional-investors-weigh-in-on-tonix-pharmaceuticals
Get-rating
Sigma-investments

Tonix Pharmaceuticals (NASDAQ:TNXP) Receives New Coverage from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Get Rating) in a report published on Sunday morning. The brokerage issued a sell rating on the stock. Separately, Alliance Global Partners restated a buy rating and issued a $6.50 price target on shares of Tonix Pharmaceuticals in a research report on Thursday, January 12th. […]

Blackrock-inc
Tang-capital-management
Tonix-pharmaceuticals
Tonix-pharmaceuticals-company-profile
News-ratings-for-tonix-pharmaceuticals-daily
Tonix-pharmaceuticals-holding-corp
Renaissance-technologies
Tonix-pharmaceuticals-price-performance
Alliance-global-partners
Institutional-investors-weigh-in-on-tonix-pharmaceuticals
Northern-trust-corp

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.